This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +22.98% per year. These returns cover a period from January 1, 1988 through April 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
coronavirus: Archive
Buy Pfizer (PFE) Stock for a Rebound After Crushing Q1 EPS Expectations?
by Shaun Pruitt
Pfizer (PFE) shares spiked 3% in Tuesday's trading session as the pharmaceutical giant was able to crush its Q1 earnings expectations.
PFEPositive Net Change JNJPositive Net Change NVOPositive Net Change LLYNegative Net Change ABBVNegative Net Change
coronavirus dividend-investing dividends earnings investing medical pharmaceuticals vaccines
Uber: Dominating Ride-Sharing and Delivery
by Andrew Rocco
Uber Technologies has morphed into a fundamental market leader with consistent profitability. In today's commentary, Stock Strategist Andrew Rocco profiles the ride-sharing leader.
DALNegative Net Change DPZNegative Net Change COSTPositive Net Change GOOGLNegative Net Change CARTPositive Net Change LYFTNegative Net Change UBERNegative Net Change DASHPositive Net Change
autonomous-vehicles coronavirus ride-hailing self-driving-cars
Pharmaceutical Stocks Hit New Highs Amid Market Volatility
by Bryan Hayes
During this time of heightened market volatility, it pays to be invested in the right places.
GILDPositive Net Change
cancer cell-therapy coronavirus earnings immuno-therapy investing medical oncology-screening vaccines
Why Novavax is Gaining Ground in COVID-19 Vaccine Race
by Andrew Rocco
Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the stock offers the best reward prospects in the industry.
SNYPositive Net Change PFEPositive Net Change MRNAPositive Net Change NVAXNegative Net Change
coronavirus vaccines
Where are the Pandemic Winners Now? ZM, SHOP, PTON
by Derek Lewis
While stay-at-home stocks were all widely hailed during 2020 and 2021, their performance since then has primarily left a sour taste in investors' mouths. Is it time to revisit them?
SHOPNegative Net Change ZMNegative Net Change PTONPositive Net Change
business-services coronavirus e-commerce tech-stocks
WHO Declares Monkeypox Public Emergency: 5 Mpox Stocks to Watch
by Andrew Rocco
Is the next pandemic here. With health officials declaring Monkeypox a public health emergency, investors need to be watching Monkeypox-related stocks.
APDNNegative Net Change TNXPPositive Net Change EBSPositive Net Change GOVXPositive Net Change VRAXPositive Net Change
biotechnology biotechs coronavirus vaccines
Bull of the Day: DoorDash (DASH)
by Andrew Rocco
DoorDash stands out as a leader in the food delivery service industry. The company's strategic expansion beyond traditional partnerships will spur revenue growth. Furthermore, the "new economy" will benefit the company for years to come.
BIGPositive Net Change DKSPositive Net Change SFMNegative Net Change GONegative Net Change DASHPositive Net Change
coronavirus earnings mobile software
Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?
by Shaun Pruitt
Despite slowing COVID-19 vaccine sales these healthcare titans are trading at more reasonable valuations with a lot of the risk-to-reward being priced into their stocks considering their earnings potential.
AZNPositive Net Change PFEPositive Net Change MRNAPositive Net Change
biotechnology cancer cell-therapy coronavirus earnings gene-therapy immuno-therapy investing medical messenger-rna pharmaceuticals vaccines
Stocks on the Mend: A Mean Reversion Duo
by Andrew Rocco
September is starting in classic, historically weak form. However, if the market finds it's footing, two stocks have explosive, reversion to the mean potential.
AMDNegative Net Change JNJPositive Net Change PFEPositive Net Change MRNAPositive Net Change NVAXNegative Net Change QQQNegative Net Change
biotechnology biotechs coronavirus investing semiconductor vaccines
Squeezing the Market: Riding the Rollercoaster of Short Squeeze Mania
by Andrew Rocco
Several stocks squeezed shorts Thursday. What does it mean for the market?
GMEPositive Net Change QQQNegative Net Change AMCPositive Net Change ARKKNegative Net Change CVNANegative Net Change BYNDPositive Net Change SPCENegative Net Change PLTRNegative Net Change
coronavirus e-commerce etfs investing reddit-stocks spac space
Bear of the Day: BioNTech (BNTX)
by Andrew Rocco
BNTX is ranked a lowly 5 for a reason. Earnings have peaked, COVID hysteria has subsided, and the technical picture is lagging.
PFEPositive Net Change BNTXPositive Net Change
biotechnology biotechs coronavirus
How Did COVID Reshape the Labor Markets
by John Blank
The latest research focuses on retirees.
NVOPositive Net Change SAPPositive Net Change STLAPositive Net Change
coronavirus economy
Boeing's Strength is Set to Continue Despite Q4 Loss
by Andrew Rocco
The world's largest aerospace company reported a Q4 loss of more than $600 million. Andrew Rocco breaks down why investors should look to the future and discount the past.
BAPositive Net Change LMTPositive Net Change DALNegative Net Change UALNegative Net Change RKLBPositive Net Change
aerospace airlines coronavirus earnings transportation travel-leisure
3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying
by Sundeep Ganoria
We present three small biotech stocks, which most analysts on Wall Street are optimistic about. These companies have upside potential for 2023 despite an uncertain macro environment.
ADAPNegative Net Change KMDAPositive Net Change ZYMEPositive Net Change
biotechnology biotechs cancer cell-therapy coronavirus immuno-therapy inflation medical
S&P 500 Overtakes Key 4,000 Level: Stocks to Watch
by Bryan Hayes
Buying pressure accelerated Tuesday afternoon, as all sectors found positive territory.
NFLXPositive Net Change MPCNegative Net Change ARRYPositive Net Change
alt-energy consumer-discretionary coronavirus dividend-investing dividends earnings energy fang inflation interest-rate investing media oil-energy solar tech-stocks
Pfizer Earnings Preview: Growth & Diversification is Key
by Shaun Pruitt
Pfizer's (PFE) Q3 earnings report on Tuesday, November 1 will give insight into its ability to sustain growth from its Covid-19 vaccines. The company's ability to beat earnings expectations may rely on the growth of other business units during the quarter.
PFEPositive Net Change JNJPositive Net Change ABBVNegative Net Change
cancer coronavirus dividend-investing dividends earnings hospitals medical oncology-screening pharmaceuticals vaccines
The Meme Stock Resurgence: Is Now the Time to Buy?
by Bryan Hayes
Recent individual rallies suggest the meme stock movement is alive and well.
GMEPositive Net Change BBBYPositive Net Change AMCPositive Net Change
coronavirus e-commerce earnings electronics gaming internet internet-content investing meme-stocks reddit-stocks social-media video-games
The Wind's at Your Back with This Shipping Sweetheart
by Bryan Hayes
Due to surges in global trade, shipping companies have witnessed a substantial improvement in terms of volumes and revenues.
EGLENo Net Change
coronavirus e-commerce earnings electronics investing transportation
Survive the Financial Armageddon Using the Zacks Rank
by Bryan Hayes
Investors can use this system to find companies that are primed to surge in price - even when most stocks are falling.
SQMNegative Net Change
agriculture basic-materials coronavirus earnings investing
Healthcare Outperformance May Signal Short-Term Market Bottom
by Bryan Hayes
This sector outperformance may be a sign the market is nearing a point of selling exhaustion.
JNJPositive Net Change XLVPositive Net Change
biotechnology biotechs cancer coronavirus dividend-investing dividends earnings etfs investing large-cap pharmaceuticals
The Commodity Surge: Is It Too Late to Buy These Leading Oil and Gas Stocks?
by Bryan Hayes
With crude prices continuing to move higher, investors would be wise to consider an allocation to these stocks.
COPNegative Net Change MROPositive Net Change
coronavirus earnings energy investing large-cap oil-energy
BioPharma Giants Print Fresh All-Time Highs
by Bryan Hayes
The trend is our friend in this market, and these two biopharmaceutical stocks are trending exceptionally well.
REGNPositive Net Change BMYPositive Net Change
biotechnology cancer cell-therapy coronavirus earnings genetics hospitals immuno-therapy investing large-cap medical medical-devices pharmaceuticals
Is It Time to Give Chinese Stocks the Green Light?
by Bryan Hayes
The notion of China weighing down emerging markets is far from a new reality.
JDPositive Net Change KWEBNegative Net Change
coronavirus e-commerce earnings emerging-markets etfs internet internet-content investing large-cap
Bull Of The Day: DocGo (DCGO)
by Brian Bolan
It may still be very early, but this company could change the way we think of non-emergency healthcare
DCGONegative Net Change
autonomous-vehicles coronavirus medical-devices smart-health
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Beat-and-raise quarter launches shares and estimates as growth in diagnostics returns
VIVONegative Net Change
coronavirus medical